post-marketing safety EU

EMA Recommends Withdrawal of Levamisole Medicines in the EU

The European Medicines Agency (EMA) has recommended the withdrawal of all medicines containing the active substance levamisole from the European Union (EU) market. The recommendation follows a detailed…